Stem-Cell Transplantation for Amyloidosis: Improving Outcomes but Not for the Faint of Heart

J Clin Oncol. 2015 Nov 10;33(32):3689-90. doi: 10.1200/JCO.2015.63.2224. Epub 2015 Sep 14.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Amyloidosis / surgery*
  • Antineoplastic Agents, Alkylating / therapeutic use*
  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Immunoglobulin Light Chains*
  • Male
  • Melphalan / therapeutic use*
  • Myeloablative Agonists / therapeutic use*

Substances

  • Antineoplastic Agents, Alkylating
  • Immunoglobulin Light Chains
  • Myeloablative Agonists
  • Melphalan